Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Chinook Therapeutics Inc (KDNY)

Chinook Therapeutics Inc (KDNY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,273,705
  • Shares Outstanding, K 63,941
  • Annual Sales, $ 51,630 K
  • Annual Income, $ -102,940 K
  • 60-Month Beta 0.10
  • Price/Sales 26.53
  • Price/Cash Flow N/A
  • Price/Book 2.49
Trade KDNY with:

Options Overview Details

View History
  • Implied Volatility 70.79% ( -3.21%)
  • Historical Volatility 47.74%
  • IV Percentile 7%
  • IV Rank 42.43%
  • IV High 164.74% on 03/14/22
  • IV Low 1.55% on 04/29/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 14
  • Volume Avg (30-Day) 233
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 0
  • Open Int (30-Day) 3,702

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.77
  • Number of Estimates 6
  • High Estimate -0.67
  • Low Estimate -0.84
  • Prior Year 0.14
  • Growth Rate Est. (year over year) -650.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.68 +1.19%
on 11/22/22
23.39 -14.84%
on 11/11/22
-1.90 (-8.71%)
since 10/25/22
3-Month
18.39 +8.32%
on 10/11/22
23.86 -16.51%
on 09/09/22
-2.49 (-11.11%)
since 08/25/22
52-Week
11.16 +78.49%
on 01/28/22
23.86 -16.51%
on 09/09/22
+3.50 (+21.32%)
since 11/24/21

Most Recent Stories

More News
Chinook Therapeutics (KDNY) Reports Q3 Loss, Tops Revenue Estimates

Chinook (KDNY) delivered earnings and revenue surprises of -33.87% and 614.57%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

KDNY : 19.92 (-7.00%)
VVOS : 0.6000 (unch)
Chinook Therapeutics (KDNY) Reports Q2 Loss, Misses Revenue Estimates

Chinook (KDNY) delivered earnings and revenue surprises of 1.61% and 83.28%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

KDNY : 19.92 (-7.00%)
TXMD : 4.46 (+5.94%)
Chinook Therapeutics Provides Business Update and Reports Second Quarter 2022 Financial Results

SEATTLE, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development...

KDNY : 19.92 (-7.00%)
Chinook Therapeutics Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SEATTLE, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development...

KDNY : 19.92 (-7.00%)
Chinook Therapeutics to Present at Upcoming Investor Conferences

SEATTLE, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development...

KDNY : 19.92 (-7.00%)
Chinook (KDNY) Is a Great Choice for "Trend" Investors, Here's Why

Chinook (KDNY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

KDNY : 19.92 (-7.00%)
Is Acadia Healthcare (ACHC) Stock Outpacing Its Medical Peers This Year?

Here is how Acadia Healthcare (ACHC) and Chinook Therapeutics (KDNY) have performed compared to their sector so far this year.

ACHC : 86.40 (-0.18%)
KDNY : 19.92 (-7.00%)
Here's Why Chinook Therapeutics (KDNY) is a Great Momentum Stock to Buy

Does Chinook Therapeutics (KDNY) have what it takes to be a top stock pick for momentum investors? Let's find out.

KDNY : 19.92 (-7.00%)
Here's Why "Trend" Investors Would Love Betting on Chinook (KDNY)

Chinook (KDNY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

KDNY : 19.92 (-7.00%)
Here's Why Viracta Therapeutics (VIRX) is Up So Far This Year

Viracta Therapeutics' (VIRX) Nana-val is being evaluated in multiple clinical studies in various subtypes of EBV-associated cancers.

SLNO : 1.0800 (-0.92%)
ASRT : 2.95 (+1.37%)
KDNY : 19.92 (-7.00%)
VIRX : 2.78 (+5.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Chinook Therapeutics, Inc. is a clinical-stage biotechnology company. It focuses on developing precision medicines for kidney diseases. Chinook Therapeutics, Inc., formerly known as Aduro Biotech Inc., is based in BERKELEY, Calif.

See More

Key Turning Points

3rd Resistance Point 22.57
2nd Resistance Point 22.02
1st Resistance Point 20.97
Last Price 19.92
1st Support Level 19.36
2nd Support Level 18.81
3rd Support Level 17.76

See More

52-Week High 23.86
Last Price 19.92
Fibonacci 61.8% 19.01
Fibonacci 50% 17.51
Fibonacci 38.2% 16.01
52-Week Low 11.16

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar